Pfizer (PFE) Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.27 +0.42 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $30.05 | 52 Week Low | $28.25 | |||
| Day High | $30.36 | P/E | 18.35 | |||
| Day Low | $29.88 | EPS | $1.65 | |||
| Volume | 10,640,100 | |||||
